Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COBRA PzF Stenting to Reduce the Duration of Triple Therapy in Patients Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

NCT02594501 is registered in ClinicalTrials.gov with CeloNova BioSciences, Inc. as lead sponsor.

NCT NCT02594501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02594501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COBRA PzF Stenting to Reduce the Duration of Triple Therapy in Patients Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
Lead sponsor
CeloNova BioSciences, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
February 5, 2016
Completion date
November 30, 2021
Enrollment
996 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

angina, stable, angina, unstable, anticoagulants